The largest database of trusted experimental protocols

15 protocols using verapamil

1

Evaluating Small-Molecule Inhibitors on Cell Proliferation

Check if the same lab product or an alternative is used in the 5 most similar protocols
To gauge the effects of small-molecule inhibitors and calcium channel blockers on proliferation of the cells, a 5-bromo-2′-deoxyuridine (BrdU) incorporation assay kit (Roche Diagnostics GmbH, Mannheim, Germany) was performed as surrogate. In our study, MEK inhibitor trametinib, AKT inhibitors capivasertib and MK-2206, and STAT3 inhibitor niclosamide (all from Selleck Chemicals, Houston, TX, USA) were employed. DMSO was used as a solvent. Additionally, the effects of MgCl2, NiCl2, and verapamil (Tocris bioscience, Bristol, UK; all dissolved in DMEM/F12) were investigated. The cells (5 × 103/well) were seeded in 96-well half-area microplates at equal densities and allowed to adhere overnight in a complete culture medium. On the following day, the culture medium was replaced by a medium supplemented with inhibitors, MgCl2 or NiCl2 at the indicated doses. After an incubation period of 32 h, BrdU was added at a final concentration of 10 µM into the culture media. Another 16 h later, labeling was stopped, and BrdU uptake was measured according to the manufacturer’s instructions.
+ Open protocol
+ Expand
2

Pharmacological Modulation of Familial DCM

Check if the same lab product or an alternative is used in the 5 most similar protocols
For pharmacological modulation of Ca2+ handling, sarcomere disarray, and apoptosis analyses, control and familial DCM hiPSC-CMs at day 20 were treated with either 10µM Carvedilol (Tocris, Bristol, United Kingdom) or 1nM Verapamil (Tocris) for 24 hours (Supplemental Table 1). Cells were washed with CDM3 media prior to in vitro stress testing with 10µM norepinephrine.
+ Open protocol
+ Expand
3

Pharmacological Modulation of Cellular Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following drugs were used: Carbamylcholine chloride (Carbachol, CCh), propranolol,
yohimbine, prazosin, L-NAME, calcium chloride (CaCl2), and hexamethonium were
purchased from Sigma Chemical Co. (Sigma-Aldrich, USA). Atropine was supplied by Research
Biochemical Incorporated, USA and Verapamil by Tocris, USA. All chemicals used were of the
analytical grade available and solubilized in distilled water.
+ Open protocol
+ Expand
4

Hsp90 Inhibitors and Epigenetic Modulators

Check if the same lab product or an alternative is used in the 5 most similar protocols
Recombinant Hsp90a protein was purchased from Enzo Life Sciences (ADI-SPP-776). DMAG-N-oxide modified geldanamycin (NPGA) was synthesized by Chris Lindsey and Craig Beeson (Drug Discovery, Medical University of South Carolina). ERK1/2 Inhibitor, SCH-229874 (S7101, Lot# 3), and EZH2 inhibitor, GSK343 (S7184), were purchased from SelleckChem. Verapamil was purchased from Tocris (0654) and Hoescht 33342 was purchased from Invitrogen (H3569). Antibodies for Snail (3895) and EZH2 (5246) were purchased from Cell Signaling. Antibody to a-tubulin (T6074) was purchased from Sigma and V5 antibody (NB600-381) was purchased from Novus Biologicals. Antibodies for Hsp90-alpha (ADI-SPA-840) and Hsp90-alpha-PE conjugate (ADI-SPA-840PE-200, Lot# 03051244C) were obtained from ENZO Lifesciences.
+ Open protocol
+ Expand
5

Pharmacological Modulation of Synaptic Transmission

Check if the same lab product or an alternative is used in the 5 most similar protocols
Pharmaceutical agents were applied via the perfusion system, in the recording chamber for 10 minutes and washed for 20 minutes. We used (in µM): 100 L-AP4 (mGluR6 agonist; L-2-amino-4-phosphonobutyric acid) and 20 NBQX (AMPA/kainate-type GluR antagonist; 2,3-Dioxo-6-nitro-1,2,3,4-tetrahydro-benzo[f]quinoxaline-7-sulfonamide) obtained from Bio Trend, 75 DL-TBOA (glutamate transporter antagonist DL-threo-β-Benzyloxy aspartic acid); 100 Verapamil (L-type voltage-gated calcium channel blocker), 50 TPMPA (GABAC receptor antagonist; 1,2,5,6-Tetrahydropyridin-4-yl)met hylphosphinic acid) and 10 Gabazine (GABAA receptor antagonist; 6-Imino-3-(4-methoxyphenyl)-1(6 H)-pyridazine-butanoic acid hydrobromide) obtained from TocrisBioscience, and 50 carbenoxolone (CBX, gap junction blocker; (3β,20β)-3-(3-Carboxy-1-oxopropoxy)-11-oxoolean-12-en-29-oic acid disodium) obtained from Sigma-Aldrich.
+ Open protocol
+ Expand
6

Chemerin Signaling Pathway Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Chemerin-9 was purchased from GenScript (#RP20248, Piscataway, NJ, USA), recombinant chemerin from BioVision (#4002, San Francisco, CA, USA), and both solubilized in deionized water. Pertussis toxin (#P7208), angiotensin II (#A9525), acetylcholine (#A6625), clonidine (#C7897) and phenylephrine (#P6126) were obtained from Sigma Chemical Company (St. Louis, MO, USA). Verapamil (#0654), Y27632 (#1254), PD098059 (#1213), and PP1 (#1397) were purchased from Tocris Bioscience (R & D, Minneapolis, MN, USA). U73122 (#70740) was purchased from Cayman Chemical (Ann Arbor, MI, USA). CCX832 was a gift from Chemocentryx (Mountain View, CA, USA).
+ Open protocol
+ Expand
7

Vasodilation Mechanisms Investigated

Check if the same lab product or an alternative is used in the 5 most similar protocols
Sodium pentobarbital was obtained from Sanofi (Brussels, Belgium), indomethacin from CERTA (Belgium), NΩ-nitro-L-arginine methyl ester (L-NAME), NΩ-nitro-L-arginine (L-NNA) and nifedipine from Sigma (Bornem, Belgium), Fura 2-AM from Molecular Probes (Invitrogen, Merelbeke, Belgium), 2-aminoethoxydiphenyl borate (2-APB), BAY K8644, levcromakalim, glibenclamide, cyclopiazonic acid (CPA), diltiazem, verapamil from TOCRIS (Bristol, United Kingdom).
+ Open protocol
+ Expand
8

Pharmacological Modulation of Familial DCM

Check if the same lab product or an alternative is used in the 5 most similar protocols
For pharmacological modulation of Ca2+ handling, sarcomere disarray, and apoptosis analyses, control and familial DCM hiPSC‐CMs at day 20 were treated with either 10 μM carvedilol (Tocris, Bristol, UK) or 1 nM verapamil (Tocris) for 24 h (Supplementary Table S1). Cells were washed with CDM3 media before in vitro stress testing with 10 μM NE.
+ Open protocol
+ Expand
9

Calcium Signaling Imaging with Fura-2

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fura-2 pentapotassium salt, Fura-2/AM, and Pluronic F-127 (20% solution in DMSO) were purchased from Life Technologies (Grand Island, NY). Verapamil and cyclopiazonic acid (CPA) were obtained from Tocris Bioscience (Minneapolis, MN). Other chemicals were from Sigma-Aldrich (St. Louis, MO). During experiments, cells were continually perfused at 0.5 ml/min (or 10 ml/min for faster drug delivery) with a physiological solution containing (in mM): 140 NaCl, 5.4 KCl, 1.5 MgCl2, 2 CaCl2, 10 glucose, and 10 HEPES (pH 7.3, 300–310 mOsm/kg). For Ca2+-free conditions, CaCl2 was replaced with 2 mM Na-EGTA.
+ Open protocol
+ Expand
10

Preparation and Use of Cardiotonic Agents

Check if the same lab product or an alternative is used in the 5 most similar protocols
Isoproterenol (ISO; Sigma Aldrich, I5627), milrinone (MIL; Tocris, 1,504), omecamtiv mecarbil (OME; Adooq Biosciences, A11206), verapamil (VER; Tocris, 0654), and Propranolol (PRO; Sigma Aldrich, P0884) solutions were prepared freshly before use. Isoproterenol and verapamil were solubilized in distilled water (Gibco, 15230-071) as 10 mM stock. Propranolol and omecamtiv mecarbil were solubilized in DMSO (Sigma, D2650) as 10 mM stock and milrinone as 50 mM stock. They were diluted in L-15 medium (Gibco, 11415-049). During measurements, the test compounds were administered directly to the wells, diluting them to the final concentrations. The amount of DMSO in the final concentrations of omecamtiv mecarbil and Propranolol did not exceed 0.003%. For milrinone, the amount of DMSO in the final concentrations was 0.002, 0.02, and 0.2%.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!